Cytek Biosciences Inc Cash Flow Reinvestment Rate
Cytek Biosciences Inc cash flow reinvestment rate. Cytek Biosciences Inc (CTKB) has a Cash Flow Reinvestment Rate of 166.57x as of June 2025, reinvesting $17.99 Million (capex $1.58 Million plus investments $-16.41 Million) from operating cash flow of $108.00K. Explore CTKB operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Cytek Biosciences Inc (2020–2024)
Cash flow reinvestment rate of Cytek Biosciences Inc from 2020 to 2024. Historical reinvestment intensity for Cytek Biosciences Inc across 4 annual periods. Explore capital reinvestment ratio of Cytek Biosciences Inc to see what proportion of operating cash flow is directed to capital expenditures.
Cytek Biosciences Inc Cash Flow Reinvestment Rate by Year (2020–2024)
Cytek Biosciences Inc cash flow reinvestment rate by year from 2020 to 2024. Year-by-year capital reinvestment analysis for Cytek Biosciences Inc. For the full cash flow conversion analysis, see CTKB cash generation efficiency.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 3.41x | $86.50 Million | $25.38 Million | $3.52 Million | ▼ -89.9% |
| 2023 | 33.87x | $178.85 Million | $5.28 Million | $4.83 Million | ▲ +518.4% |
| 2021 | 5.48x | $25.36 Million | $4.63 Million | $4.36 Million | ▲ +2582.8% |
| 2020 | 0.20x | $3.09 Million | $15.16 Million | $1.55 Million | — |